View ValuationYongyue Science&TechnologyLtd 将来の成長Future 基準チェック /06現在、 Yongyue Science&TechnologyLtdの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長30.1%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesNew Risk • Apr 21New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CN¥31m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥31m free cash flow). Earnings have declined by 57% per year over the past 5 years.Reported Earnings • Apr 21Full year 2025 earnings released: CN¥0.15 loss per share (vs CN¥0.46 loss in FY 2024)Full year 2025 results: CN¥0.15 loss per share (improved from CN¥0.46 loss in FY 2024). Revenue: CN¥329.7m (down 11% from FY 2024). Net loss: CN¥53.1m (loss narrowed 68% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.お知らせ • Apr 21Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 15, 2026Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 15, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Quanzhou, Fujian Chinaお知らせ • Mar 30Yongyue Science&Technology Co.,Ltd to Report Q1, 2026 Results on Apr 30, 2026Yongyue Science&Technology Co.,Ltd announced that they will report Q1, 2026 results on Apr 30, 2026お知らせ • Dec 26Yongyue Science&Technology Co.,Ltd to Report Fiscal Year 2025 Results on Apr 21, 2026Yongyue Science&Technology Co.,Ltd announced that they will report fiscal year 2025 results on Apr 21, 2026New Risk • Dec 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 65% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.5% average weekly change).Board Change • Oct 29Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Shuzhi Xie was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Sep 30Yongyue Science&Technology Co.,Ltd to Report Q3, 2025 Results on Oct 31, 2025Yongyue Science&Technology Co.,Ltd announced that they will report Q3, 2025 results on Oct 31, 2025New Risk • Jul 08New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 9.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥38m free cash flow). Share price has been highly volatile over the past 3 months (9.4% average weekly change). Earnings have declined by 72% per year over the past 5 years.お知らせ • Jun 30Yongyue Science&Technology Co.,Ltd to Report First Half, 2025 Results on Aug 30, 2025Yongyue Science&Technology Co.,Ltd announced that they will report first half, 2025 results on Aug 30, 2025New Risk • Jun 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥38m free cash flow). Earnings have declined by 72% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.3% average weekly change).New Risk • May 08New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CN¥38m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥38m free cash flow). Earnings have declined by 72% per year over the past 5 years.Reported Earnings • Apr 03Full year 2024 earnings released: CN¥0.46 loss per share (vs CN¥0.19 loss in FY 2023)Full year 2024 results: CN¥0.46 loss per share (further deteriorated from CN¥0.19 loss in FY 2023). Revenue: CN¥370.4m (up 9.7% from FY 2023). Net loss: CN¥165.5m (loss widened 136% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.お知らせ • Apr 03Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 09, 2025Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 09, 2025, at 14:00 China Standard Time. Location: Office Building 5, College Student Entrepreneurship Park, East of Yongsheng Road and South of Ruifeng Road, Dazhong Subdistrict, Dafeng District, Yancheng, Jiangsu Chinaお知らせ • Mar 28Yongyue Science&Technology Co.,Ltd to Report Q1, 2025 Results on Apr 30, 2025Yongyue Science&Technology Co.,Ltd announced that they will report Q1, 2025 results on Apr 30, 2025お知らせ • Dec 27Yongyue Science&Technology Co.,Ltd to Report Fiscal Year 2024 Results on Mar 31, 2025Yongyue Science&Technology Co.,Ltd announced that they will report fiscal year 2024 results on Mar 31, 2025分析記事 • Nov 29Optimistic Investors Push Yongyue Science&Technology Co.,Ltd (SHSE:603879) Shares Up 32% But Growth Is LackingYongyue Science&Technology Co.,Ltd ( SHSE:603879 ) shares have continued their recent momentum with a 32% gain in the...Reported Earnings • Nov 02Third quarter 2024 earnings released: CN¥0.025 loss per share (vs CN¥0.037 loss in 3Q 2023)Third quarter 2024 results: CN¥0.025 loss per share (improved from CN¥0.037 loss in 3Q 2023). Revenue: CN¥103.9m (up 16% from 3Q 2023). Net loss: CN¥8.91m (loss narrowed 32% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 61 percentage points per year, which is a significant difference in performance.お知らせ • Sep 30Yongyue Science&Technology Co.,Ltd to Report Q3, 2024 Results on Oct 30, 2024Yongyue Science&Technology Co.,Ltd announced that they will report Q3, 2024 results on Oct 30, 2024Reported Earnings • Aug 29Second quarter 2024 earnings released: CN¥0.036 loss per share (vs CN¥0.032 loss in 2Q 2023)Second quarter 2024 results: CN¥0.036 loss per share (further deteriorated from CN¥0.032 loss in 2Q 2023). Revenue: CN¥94.0m (up 7.4% from 2Q 2023). Net loss: CN¥12.8m (loss widened 11% from 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 68 percentage points per year, which is a significant difference in performance.分析記事 • Jul 25Yongyue Science&Technology Co.,Ltd (SHSE:603879) Stock Rockets 29% As Investors Are Less Pessimistic Than ExpectedYongyue Science&Technology Co.,Ltd ( SHSE:603879 ) shareholders are no doubt pleased to see that the share price has...お知らせ • Jun 28Yongyue Science&Technology Co.,Ltd to Report First Half, 2024 Results on Aug 29, 2024Yongyue Science&Technology Co.,Ltd announced that they will report first half, 2024 results on Aug 29, 2024New Risk • Jun 25New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: CN¥707.0m (US$97.3m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 77% per year over the past 5 years. Minor Risk Market cap is less than US$100m (CN¥707.0m market cap, or US$97.3m).分析記事 • Jun 05Risks Still Elevated At These Prices As Yongyue Science&Technology Co.,Ltd (SHSE:603879) Shares Dive 52%Yongyue Science&Technology Co.,Ltd ( SHSE:603879 ) shareholders that were waiting for something to happen have been...New Risk • Jun 05New major risk - Revenue and earnings growthEarnings have declined by 77% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 77% per year over the past 5 years.New Risk • May 14New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 74% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported September 2023 fiscal period end).お知らせ • May 01Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 30, 2024Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 30, 2024, at 14:00 China Standard Time. Location: 7F, No. 16, Hongwu North Road, Xuanwu District, Nanjing, Jiangsu China分析記事 • Apr 15Yongyue Science&Technology Co.,Ltd (SHSE:603879) May Have Run Too Fast Too Soon With Recent 29% Price PlummetYongyue Science&Technology Co.,Ltd ( SHSE:603879 ) shares have had a horrible month, losing 29% after a relatively good...お知らせ • Mar 29Yongyue Science&Technology Co.,Ltd to Report Q1, 2024 Results on Apr 30, 2024Yongyue Science&Technology Co.,Ltd announced that they will report Q1, 2024 results on Apr 30, 2024New Risk • Feb 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 74% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (9.0% average weekly change).お知らせ • Feb 27Yongyue Science&Technology Co.,Ltd (SHSE:603879) announces an Equity Buyback for CNY 30 million worth of its shares.Yongyue Science&Technology Co.,Ltd (SHSE:603879) announces a share repurchase program. Under the program, the company will repurchase up to CNY 30 million worth of its shares. The shares will be repurchased at a price not more than CNY 6 per share. The repurchased shares will be used to safeguard the company's value and shareholders' rights. The program will be valid for a period of 3 months.分析記事 • Feb 26Yongyue Science&Technology Co.,Ltd's (SHSE:603879) Popularity With Investors Under Threat As Stock Sinks 26%To the annoyance of some shareholders, Yongyue Science&Technology Co.,Ltd ( SHSE:603879 ) shares are down a...お知らせ • Dec 29Yongyue Science&Technology Co.,Ltd to Report Fiscal Year 2023 Results on Apr 30, 2024Yongyue Science&Technology Co.,Ltd announced that they will report fiscal year 2023 results on Apr 30, 2024Reported Earnings • Aug 30Second quarter 2023 earnings released: CN¥0.032 loss per share (vs CN¥0.008 loss in 2Q 2022)Second quarter 2023 results: CN¥0.032 loss per share (further deteriorated from CN¥0.008 loss in 2Q 2022). Revenue: CN¥87.5m (up 10% from 2Q 2022). Net loss: CN¥11.5m (loss widened 291% from 2Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 136 percentage points per year, which is a significant difference in performance.New Risk • Jul 25New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 65% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (6.7% average weekly change).お知らせ • Jun 28Yongyue Science&Technology Co.,Ltd to Report First Half, 2023 Results on Aug 30, 2023Yongyue Science&Technology Co.,Ltd announced that they will report first half, 2023 results on Aug 30, 2023Reported Earnings • Apr 29First quarter 2023 earnings released: CN¥0.017 loss per share (vs CN¥0.006 loss in 1Q 2022)First quarter 2023 results: CN¥0.017 loss per share (further deteriorated from CN¥0.006 loss in 1Q 2022). Revenue: CN¥60.0m (up 13% from 1Q 2022). Net loss: CN¥6.00m (loss widened 185% from 1Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 102 percentage points per year, which is a significant difference in performance.Board Change • Nov 16Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. 2 independent directors (4 non-independent directors). GM & Vice Chairman Weida Xu is the most experienced director on the board, commencing their role in 2017. Independent Director Yu Wu was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Reported Earnings • Oct 28Third quarter 2022 earnings released: CN¥0.032 loss per share (vs CN¥0.003 profit in 3Q 2021)Third quarter 2022 results: CN¥0.032 loss per share (down from CN¥0.003 profit in 3Q 2021). Revenue: CN¥84.5m (down 18% from 3Q 2021). Net loss: CN¥11.5m (down CN¥12.6m from profit in 3Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.Reported Earnings • Aug 31Second quarter 2022 earnings released: CN¥0.008 loss per share (vs CN¥0.012 profit in 2Q 2021)Second quarter 2022 results: CN¥0.008 loss per share (down from CN¥0.012 profit in 2Q 2021). Revenue: CN¥79.4m (down 32% from 2Q 2021). Net loss: CN¥2.95m (down 181% from profit in 2Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance.Board Change • Aug 25Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. 2 independent directors (4 non-independent directors). GM & Vice Chairman Weida Xu is the most experienced director on the board, commencing their role in 2017. Independent Director Yu Wu was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Reported Earnings • May 02First quarter 2022 earnings released: CN¥0.006 loss per share (vs CN¥0.008 profit in 1Q 2021)First quarter 2022 results: CN¥0.006 loss per share (down from CN¥0.008 profit in 1Q 2021). Revenue: CN¥53.2m (down 43% from 1Q 2021). Net loss: CN¥2.11m (down 166% from profit in 1Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Apr 21Full year 2021 earnings released: EPS: CN¥0.018 (vs CN¥0.015 in FY 2020)Full year 2021 results: EPS: CN¥0.018 (up from CN¥0.015 in FY 2020). Revenue: CN¥396.2m (down 2.5% from FY 2020). Net income: CN¥6.43m (up 2.8% from FY 2020). Profit margin: 1.6% (up from 1.5% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.Reported Earnings • Oct 28Third quarter 2021 earnings released: EPS CN¥0.003 (vs CN¥0.008 loss in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: CN¥103.4m (down 10.0% from 3Q 2020). Net income: CN¥1.13m (up CN¥3.91m from 3Q 2020). Profit margin: 1.1% (up from net loss in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.Reported Earnings • Aug 20Second quarter 2021 earnings released: EPS CN¥0.012 (vs CN¥0.014 in 2Q 2020)The company reported a mediocre second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥116.1m (up 33% from 2Q 2020). Net income: CN¥3.64m (down 27% from 2Q 2020). Profit margin: 3.1% (down from 5.7% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.Reported Earnings • Apr 20Full year 2020 earnings released: EPS CN¥0.02 (vs CN¥0.086 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥406.4m (down 5.2% from FY 2019). Net income: CN¥6.25m (down 74% from FY 2019). Profit margin: 1.5% (down from 5.7% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.Is New 90 Day High Low • Feb 08New 90-day low: CN¥6.36The company is down 25% from its price of CN¥8.49 on 10 November 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.お知らせ • Jan 22Jiangsu Huaying Enterprise Management Co., Ltd. completed the acquisition of 17.1% stake in Yongyue Science&Technology Co.,Ltd (SHSE:603879) from Fu Wenchang, Fu Shuifa, Fu Wenying and Chen Zhishan.Jiangsu Huaying Enterprise Management Co., Ltd. signed a share transfer intention agreement to acquire 17.1% stake in Yongyue Science&Technology Co.,Ltd (SHSE:603879) from Fu Wenchang, Fu Shuifa, Fu Wenying and Chen Zhishan for approximately CNY 620 million on November 11, 2020. Under the terms of the transaction, Jiangsu Huaying will acquire 47.8 million shares of Yongyue Science&Technology for CNY 12.8 per share. Within 3 working days from the date of signing the agreement, a deposit of CNY 100 million shall be paid. Before the transaction, Fu Wenchang, Fu Shuifa, Fu Xiuzhen and Fu Wenying held 102.9 million shares or 36.83% stake while Chen Zhishan held 37.6 million shares or 13.46% stake in in Yongyue Science&Technology. Upon completion of the transaction, Fu Wenchang, Fu Shuifa, Fu Xiuzhen and Fu Wenying will hold 64.5 million shares or 23.08% stake while Chen Zhishan will hold 28.2 million shares or 10.1% stake. Jiangsu Huaying Enterprise Management Co., Ltd. completed the acquisition of 17.1% stake in Yongyue Science&Technology Co.,Ltd (SHSE:603879) from Fu Wenchang, Fu Shuifa, Fu Wenying and Chen Zhishan on January 20, 2021.Is New 90 Day High Low • Jan 06New 90-day low: CN¥7.18The company is down 2.0% from its price of CN¥7.36 on 30 September 2020. The Chinese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 18% over the same period.Is New 90 Day High Low • Dec 01New 90-day high: CN¥8.51The company is up 3.0% from its price of CN¥8.30 on 02 September 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 3.0% over the same period.Reported Earnings • Oct 25Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥2.82m, down 88% from the prior year. Total revenue was CN¥370.5m over the last 12 months, down 22% from the prior year.お知らせ • Oct 20Yongyue Science&Technology Co.,Ltd to Report Q3, 2020 Results on Oct 24, 2020Yongyue Science&Technology Co.,Ltd announced that they will report Q3, 2020 results on Oct 24, 2020お知らせ • Jul 09Yongyue Science&Technology Co.,Ltd to Report First Half, 2020 Results on Aug 21, 2020Yongyue Science&Technology Co.,Ltd announced that they will report first half, 2020 results on Aug 21, 2020 このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Yongyue Science&TechnologyLtd は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測SHSE:603879 - アナリストの将来予測と過去の財務データ ( )CNY Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/2026336-54-31-30N/A12/31/2025330-53-31-30N/A9/30/2025338-14166N/A6/30/2025361-147-25-24N/A3/31/2025366-159-38-38N/A12/31/2024370-161-36-36N/A9/30/2024363-73-64-74N/A6/30/2024349-77-54-17N/A3/31/2024342-76-69-2N/A12/31/2023338-70-115-44N/A9/30/2023316-53-97-39N/A6/30/2023311-52-99-53N/A3/31/2023303-43-70-52N/A12/31/2022296-39-4819N/A9/30/2022301-18-5931N/A6/30/2022320-5-3126N/A3/31/20223571-1837N/A12/31/202139661012N/A9/30/2021464162931N/A6/30/2021475122931N/A3/31/2021447133435N/A12/31/2020406603N/A9/30/20203703-112N/A6/30/2020360131433N/A3/31/202038515-1117N/A12/31/201942924N/A17N/A9/30/201947524N/A72N/A6/30/201955429N/A32N/A3/31/201960234N/A16N/A12/31/201860837N/A28N/A9/30/201859742N/A-16N/A6/30/201855843N/A-14N/A3/31/201855245N/A15N/A12/31/201755944N/A26N/A9/30/201756551N/A19N/A6/30/201757549N/A11N/A3/31/201756648N/A36N/A12/31/201653647N/A37N/A12/31/201554942N/A64N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 603879の予測収益成長が 貯蓄率 ( 2.4% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 603879の収益がCN市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 603879の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 603879の収益がCN市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 603879の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 603879の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/16 12:00終値2026/06/16 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Yongyue Science&Technology Co.,Ltd 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
New Risk • Apr 21New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CN¥31m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥31m free cash flow). Earnings have declined by 57% per year over the past 5 years.
Reported Earnings • Apr 21Full year 2025 earnings released: CN¥0.15 loss per share (vs CN¥0.46 loss in FY 2024)Full year 2025 results: CN¥0.15 loss per share (improved from CN¥0.46 loss in FY 2024). Revenue: CN¥329.7m (down 11% from FY 2024). Net loss: CN¥53.1m (loss narrowed 68% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
お知らせ • Apr 21Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 15, 2026Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 15, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Quanzhou, Fujian China
お知らせ • Mar 30Yongyue Science&Technology Co.,Ltd to Report Q1, 2026 Results on Apr 30, 2026Yongyue Science&Technology Co.,Ltd announced that they will report Q1, 2026 results on Apr 30, 2026
お知らせ • Dec 26Yongyue Science&Technology Co.,Ltd to Report Fiscal Year 2025 Results on Apr 21, 2026Yongyue Science&Technology Co.,Ltd announced that they will report fiscal year 2025 results on Apr 21, 2026
New Risk • Dec 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 65% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.5% average weekly change).
Board Change • Oct 29Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Shuzhi Xie was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Sep 30Yongyue Science&Technology Co.,Ltd to Report Q3, 2025 Results on Oct 31, 2025Yongyue Science&Technology Co.,Ltd announced that they will report Q3, 2025 results on Oct 31, 2025
New Risk • Jul 08New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 9.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥38m free cash flow). Share price has been highly volatile over the past 3 months (9.4% average weekly change). Earnings have declined by 72% per year over the past 5 years.
お知らせ • Jun 30Yongyue Science&Technology Co.,Ltd to Report First Half, 2025 Results on Aug 30, 2025Yongyue Science&Technology Co.,Ltd announced that they will report first half, 2025 results on Aug 30, 2025
New Risk • Jun 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥38m free cash flow). Earnings have declined by 72% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.3% average weekly change).
New Risk • May 08New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CN¥38m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥38m free cash flow). Earnings have declined by 72% per year over the past 5 years.
Reported Earnings • Apr 03Full year 2024 earnings released: CN¥0.46 loss per share (vs CN¥0.19 loss in FY 2023)Full year 2024 results: CN¥0.46 loss per share (further deteriorated from CN¥0.19 loss in FY 2023). Revenue: CN¥370.4m (up 9.7% from FY 2023). Net loss: CN¥165.5m (loss widened 136% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.
お知らせ • Apr 03Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 09, 2025Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 09, 2025, at 14:00 China Standard Time. Location: Office Building 5, College Student Entrepreneurship Park, East of Yongsheng Road and South of Ruifeng Road, Dazhong Subdistrict, Dafeng District, Yancheng, Jiangsu China
お知らせ • Mar 28Yongyue Science&Technology Co.,Ltd to Report Q1, 2025 Results on Apr 30, 2025Yongyue Science&Technology Co.,Ltd announced that they will report Q1, 2025 results on Apr 30, 2025
お知らせ • Dec 27Yongyue Science&Technology Co.,Ltd to Report Fiscal Year 2024 Results on Mar 31, 2025Yongyue Science&Technology Co.,Ltd announced that they will report fiscal year 2024 results on Mar 31, 2025
分析記事 • Nov 29Optimistic Investors Push Yongyue Science&Technology Co.,Ltd (SHSE:603879) Shares Up 32% But Growth Is LackingYongyue Science&Technology Co.,Ltd ( SHSE:603879 ) shares have continued their recent momentum with a 32% gain in the...
Reported Earnings • Nov 02Third quarter 2024 earnings released: CN¥0.025 loss per share (vs CN¥0.037 loss in 3Q 2023)Third quarter 2024 results: CN¥0.025 loss per share (improved from CN¥0.037 loss in 3Q 2023). Revenue: CN¥103.9m (up 16% from 3Q 2023). Net loss: CN¥8.91m (loss narrowed 32% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 61 percentage points per year, which is a significant difference in performance.
お知らせ • Sep 30Yongyue Science&Technology Co.,Ltd to Report Q3, 2024 Results on Oct 30, 2024Yongyue Science&Technology Co.,Ltd announced that they will report Q3, 2024 results on Oct 30, 2024
Reported Earnings • Aug 29Second quarter 2024 earnings released: CN¥0.036 loss per share (vs CN¥0.032 loss in 2Q 2023)Second quarter 2024 results: CN¥0.036 loss per share (further deteriorated from CN¥0.032 loss in 2Q 2023). Revenue: CN¥94.0m (up 7.4% from 2Q 2023). Net loss: CN¥12.8m (loss widened 11% from 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 68 percentage points per year, which is a significant difference in performance.
分析記事 • Jul 25Yongyue Science&Technology Co.,Ltd (SHSE:603879) Stock Rockets 29% As Investors Are Less Pessimistic Than ExpectedYongyue Science&Technology Co.,Ltd ( SHSE:603879 ) shareholders are no doubt pleased to see that the share price has...
お知らせ • Jun 28Yongyue Science&Technology Co.,Ltd to Report First Half, 2024 Results on Aug 29, 2024Yongyue Science&Technology Co.,Ltd announced that they will report first half, 2024 results on Aug 29, 2024
New Risk • Jun 25New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: CN¥707.0m (US$97.3m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 77% per year over the past 5 years. Minor Risk Market cap is less than US$100m (CN¥707.0m market cap, or US$97.3m).
分析記事 • Jun 05Risks Still Elevated At These Prices As Yongyue Science&Technology Co.,Ltd (SHSE:603879) Shares Dive 52%Yongyue Science&Technology Co.,Ltd ( SHSE:603879 ) shareholders that were waiting for something to happen have been...
New Risk • Jun 05New major risk - Revenue and earnings growthEarnings have declined by 77% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 77% per year over the past 5 years.
New Risk • May 14New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 74% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported September 2023 fiscal period end).
お知らせ • May 01Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 30, 2024Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 30, 2024, at 14:00 China Standard Time. Location: 7F, No. 16, Hongwu North Road, Xuanwu District, Nanjing, Jiangsu China
分析記事 • Apr 15Yongyue Science&Technology Co.,Ltd (SHSE:603879) May Have Run Too Fast Too Soon With Recent 29% Price PlummetYongyue Science&Technology Co.,Ltd ( SHSE:603879 ) shares have had a horrible month, losing 29% after a relatively good...
お知らせ • Mar 29Yongyue Science&Technology Co.,Ltd to Report Q1, 2024 Results on Apr 30, 2024Yongyue Science&Technology Co.,Ltd announced that they will report Q1, 2024 results on Apr 30, 2024
New Risk • Feb 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 74% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (9.0% average weekly change).
お知らせ • Feb 27Yongyue Science&Technology Co.,Ltd (SHSE:603879) announces an Equity Buyback for CNY 30 million worth of its shares.Yongyue Science&Technology Co.,Ltd (SHSE:603879) announces a share repurchase program. Under the program, the company will repurchase up to CNY 30 million worth of its shares. The shares will be repurchased at a price not more than CNY 6 per share. The repurchased shares will be used to safeguard the company's value and shareholders' rights. The program will be valid for a period of 3 months.
分析記事 • Feb 26Yongyue Science&Technology Co.,Ltd's (SHSE:603879) Popularity With Investors Under Threat As Stock Sinks 26%To the annoyance of some shareholders, Yongyue Science&Technology Co.,Ltd ( SHSE:603879 ) shares are down a...
お知らせ • Dec 29Yongyue Science&Technology Co.,Ltd to Report Fiscal Year 2023 Results on Apr 30, 2024Yongyue Science&Technology Co.,Ltd announced that they will report fiscal year 2023 results on Apr 30, 2024
Reported Earnings • Aug 30Second quarter 2023 earnings released: CN¥0.032 loss per share (vs CN¥0.008 loss in 2Q 2022)Second quarter 2023 results: CN¥0.032 loss per share (further deteriorated from CN¥0.008 loss in 2Q 2022). Revenue: CN¥87.5m (up 10% from 2Q 2022). Net loss: CN¥11.5m (loss widened 291% from 2Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 136 percentage points per year, which is a significant difference in performance.
New Risk • Jul 25New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 65% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (6.7% average weekly change).
お知らせ • Jun 28Yongyue Science&Technology Co.,Ltd to Report First Half, 2023 Results on Aug 30, 2023Yongyue Science&Technology Co.,Ltd announced that they will report first half, 2023 results on Aug 30, 2023
Reported Earnings • Apr 29First quarter 2023 earnings released: CN¥0.017 loss per share (vs CN¥0.006 loss in 1Q 2022)First quarter 2023 results: CN¥0.017 loss per share (further deteriorated from CN¥0.006 loss in 1Q 2022). Revenue: CN¥60.0m (up 13% from 1Q 2022). Net loss: CN¥6.00m (loss widened 185% from 1Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 102 percentage points per year, which is a significant difference in performance.
Board Change • Nov 16Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. 2 independent directors (4 non-independent directors). GM & Vice Chairman Weida Xu is the most experienced director on the board, commencing their role in 2017. Independent Director Yu Wu was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Reported Earnings • Oct 28Third quarter 2022 earnings released: CN¥0.032 loss per share (vs CN¥0.003 profit in 3Q 2021)Third quarter 2022 results: CN¥0.032 loss per share (down from CN¥0.003 profit in 3Q 2021). Revenue: CN¥84.5m (down 18% from 3Q 2021). Net loss: CN¥11.5m (down CN¥12.6m from profit in 3Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.
Reported Earnings • Aug 31Second quarter 2022 earnings released: CN¥0.008 loss per share (vs CN¥0.012 profit in 2Q 2021)Second quarter 2022 results: CN¥0.008 loss per share (down from CN¥0.012 profit in 2Q 2021). Revenue: CN¥79.4m (down 32% from 2Q 2021). Net loss: CN¥2.95m (down 181% from profit in 2Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance.
Board Change • Aug 25Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. 2 independent directors (4 non-independent directors). GM & Vice Chairman Weida Xu is the most experienced director on the board, commencing their role in 2017. Independent Director Yu Wu was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Reported Earnings • May 02First quarter 2022 earnings released: CN¥0.006 loss per share (vs CN¥0.008 profit in 1Q 2021)First quarter 2022 results: CN¥0.006 loss per share (down from CN¥0.008 profit in 1Q 2021). Revenue: CN¥53.2m (down 43% from 1Q 2021). Net loss: CN¥2.11m (down 166% from profit in 1Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Apr 21Full year 2021 earnings released: EPS: CN¥0.018 (vs CN¥0.015 in FY 2020)Full year 2021 results: EPS: CN¥0.018 (up from CN¥0.015 in FY 2020). Revenue: CN¥396.2m (down 2.5% from FY 2020). Net income: CN¥6.43m (up 2.8% from FY 2020). Profit margin: 1.6% (up from 1.5% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.
Reported Earnings • Oct 28Third quarter 2021 earnings released: EPS CN¥0.003 (vs CN¥0.008 loss in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: CN¥103.4m (down 10.0% from 3Q 2020). Net income: CN¥1.13m (up CN¥3.91m from 3Q 2020). Profit margin: 1.1% (up from net loss in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.
Reported Earnings • Aug 20Second quarter 2021 earnings released: EPS CN¥0.012 (vs CN¥0.014 in 2Q 2020)The company reported a mediocre second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥116.1m (up 33% from 2Q 2020). Net income: CN¥3.64m (down 27% from 2Q 2020). Profit margin: 3.1% (down from 5.7% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.
Reported Earnings • Apr 20Full year 2020 earnings released: EPS CN¥0.02 (vs CN¥0.086 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥406.4m (down 5.2% from FY 2019). Net income: CN¥6.25m (down 74% from FY 2019). Profit margin: 1.5% (down from 5.7% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.
Is New 90 Day High Low • Feb 08New 90-day low: CN¥6.36The company is down 25% from its price of CN¥8.49 on 10 November 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.
お知らせ • Jan 22Jiangsu Huaying Enterprise Management Co., Ltd. completed the acquisition of 17.1% stake in Yongyue Science&Technology Co.,Ltd (SHSE:603879) from Fu Wenchang, Fu Shuifa, Fu Wenying and Chen Zhishan.Jiangsu Huaying Enterprise Management Co., Ltd. signed a share transfer intention agreement to acquire 17.1% stake in Yongyue Science&Technology Co.,Ltd (SHSE:603879) from Fu Wenchang, Fu Shuifa, Fu Wenying and Chen Zhishan for approximately CNY 620 million on November 11, 2020. Under the terms of the transaction, Jiangsu Huaying will acquire 47.8 million shares of Yongyue Science&Technology for CNY 12.8 per share. Within 3 working days from the date of signing the agreement, a deposit of CNY 100 million shall be paid. Before the transaction, Fu Wenchang, Fu Shuifa, Fu Xiuzhen and Fu Wenying held 102.9 million shares or 36.83% stake while Chen Zhishan held 37.6 million shares or 13.46% stake in in Yongyue Science&Technology. Upon completion of the transaction, Fu Wenchang, Fu Shuifa, Fu Xiuzhen and Fu Wenying will hold 64.5 million shares or 23.08% stake while Chen Zhishan will hold 28.2 million shares or 10.1% stake. Jiangsu Huaying Enterprise Management Co., Ltd. completed the acquisition of 17.1% stake in Yongyue Science&Technology Co.,Ltd (SHSE:603879) from Fu Wenchang, Fu Shuifa, Fu Wenying and Chen Zhishan on January 20, 2021.
Is New 90 Day High Low • Jan 06New 90-day low: CN¥7.18The company is down 2.0% from its price of CN¥7.36 on 30 September 2020. The Chinese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 18% over the same period.
Is New 90 Day High Low • Dec 01New 90-day high: CN¥8.51The company is up 3.0% from its price of CN¥8.30 on 02 September 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 3.0% over the same period.
Reported Earnings • Oct 25Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥2.82m, down 88% from the prior year. Total revenue was CN¥370.5m over the last 12 months, down 22% from the prior year.
お知らせ • Oct 20Yongyue Science&Technology Co.,Ltd to Report Q3, 2020 Results on Oct 24, 2020Yongyue Science&Technology Co.,Ltd announced that they will report Q3, 2020 results on Oct 24, 2020
お知らせ • Jul 09Yongyue Science&Technology Co.,Ltd to Report First Half, 2020 Results on Aug 21, 2020Yongyue Science&Technology Co.,Ltd announced that they will report first half, 2020 results on Aug 21, 2020